Literature DB >> 24558853

[Strategy and core technologies for the secondary development of Chinese patent medicine].

Bo-Li Zhagn1, Xiao-Hui Fan2, Yang Liu1, Hai-Bin Qu1, Jun-Hua Zhang1, Yi-Yu Chegn2.   

Abstract

Secondary development of Chinese Patent Medicine (CPM) is an effective and innovation-driven way for the leaping development of Chinese medicine industry with less investment and faster return. Aim to improving the efficacy, safety and batch-to-batch consistency of CPMs, the theory and methodology for the secondary development of CPMs, mode for cultivating superior CPM, approaches to reforming the pharmaceutical technology and the corresponding core technologies were proposed in this paper, which is summarized as 'One objective, Three analyses, Five definitudes and Seven improvements'.

Mesh:

Substances:

Year:  2013        PMID: 24558853

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

Review 1.  Innovative development path of ethnomedicines: the interpretation of the path.

Authors:  Zhaoyun Zhu; Dehuan Fu; Yali Gui; Tao Cui; Jingkun Wang; Ting Wang; Zhizhong Yang; Yanfei Niu; Zhennan She; Li Wang
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

Review 2.  Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions.

Authors:  Annie Xianghong Lin; Ging Chan; Yuanjia Hu; Defang Ouyang; Carolina Oi Lam Ung; Luwen Shi; Hao Hu
Journal:  Chin Med       Date:  2018-02-09       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.